Asmae Toumi1,2,3, Catherine DiGennaro1,2,3, Vahab Vahdat1,2,3, Mohammad S Jalali1,3, G Scott Gazelle1,3, Jagpreet Chhatwal1,3, Rachel R Kelz4, Carrie C Lubitz1,2,3. 1. Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts, USA. 2. Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA. 3. Division of Surgical Oncology, Harvard Medical School, Boston, Massachusetts, USA. 4. Department of Surgery, Center for Surgery and Health Economics, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Abstract
Background: The American Thyroid Association (ATA) published the 2015 Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer, recommending a shift to less aggressive diagnostic, surgical, and postoperative treatment strategies. At the same time and perhaps related to the new guidelines, there has been a shift to outpatient thyroid surgery. The aim of the current study was to assess physician adherence to these recommendations by identifying and quantifying temporal trends in the rates and indications for thyroid procedures in the inpatient and outpatient settings. Methods: Using the IBM® MarketScan® Commercial database, we identified employer-insured patients in the United States who underwent outpatient and inpatient thyroid surgery from 2007 to 2018. Thyroid surgery was classified as total thyroidectomy (TT), thyroid lobectomy (TL), or a completion thyroidectomy. The surgical indication diagnosis was also determined and classified as either benign or malignant thyroid disease. We compared outpatient and inpatient trends in surgery between benign and malignant thyroid disease both before and after the release of the 2015 ATA guidelines. Results: A total of 220,088 patients who underwent thyroid surgery were included in the analysis. Approximately 80% of TLs were performed in the outpatient setting versus 70% of TTs. Longitudinal analysis showed a statistically significant changepoint for TT proportion occurring in November 2015. The proportion of TT as compared with TL decreased from 80% in September 2015 to 39% by December 2018. For thyroid cancer, there is an increasing trend in performing TL over TT, increasing from 17% in 2015 to 28% by the end of 2018. Conclusions: There was a significant changepoint occurring in November 2015 in the operative and management trends for benign and malignant thyroid disease.
Background: The American Thyroid Association (ATA) published the 2015 Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer, recommending a shift to less aggressive diagnostic, surgical, and postoperative treatment strategies. At the same time and perhaps related to the new guidelines, there has been a shift to outpatient thyroid surgery. The aim of the current study was to assess physician adherence to these recommendations by identifying and quantifying temporal trends in the rates and indications for thyroid procedures in the inpatient and outpatient settings. Methods: Using the IBM® MarketScan® Commercial database, we identified employer-insured patients in the United States who underwent outpatient and inpatient thyroid surgery from 2007 to 2018. Thyroid surgery was classified as total thyroidectomy (TT), thyroid lobectomy (TL), or a completion thyroidectomy. The surgical indication diagnosis was also determined and classified as either benign or malignant thyroid disease. We compared outpatient and inpatient trends in surgery between benign and malignant thyroid disease both before and after the release of the 2015 ATA guidelines. Results: A total of 220,088 patients who underwent thyroid surgery were included in the analysis. Approximately 80% of TLs were performed in the outpatient setting versus 70% of TTs. Longitudinal analysis showed a statistically significant changepoint for TT proportion occurring in November 2015. The proportion of TT as compared with TL decreased from 80% in September 2015 to 39% by December 2018. For thyroid cancer, there is an increasing trend in performing TL over TT, increasing from 17% in 2015 to 28% by the end of 2018. Conclusions: There was a significant changepoint occurring in November 2015 in the operative and management trends for benign and malignant thyroid disease.
Authors: John M Hollingsworth; Russell J Funk; Spencer A Garrison; Jason Owen-Smith; Samuel R Kaufman; Bruce E Landon; John D Birkmeyer Journal: Med Care Date: 2015-02 Impact factor: 2.983
Authors: Mohamed Abdelgadir Adam; Paolo Goffredo; Linda Youngwirth; Randall P Scheri; Sanziana A Roman; Julie A Sosa Journal: Surgery Date: 2015-10-02 Impact factor: 3.982
Authors: David J Terris; Samuel Snyder; Denise Carneiro-Pla; William B Inabnet; Emad Kandil; Lisa Orloff; Maisie Shindo; Ralph P Tufano; R Michael Tuttle; Mark Urken; Michael W Yeh Journal: Thyroid Date: 2013-09-14 Impact factor: 6.568
Authors: Megan R Haymart; Mousumi Banerjee; Andrew K Stewart; Ronald J Koenig; John D Birkmeyer; Jennifer J Griggs Journal: JAMA Date: 2011-08-17 Impact factor: 56.272
Authors: Timothy M Ullmann; Katherine D Gray; Dessislava Stefanova; Jessica Limberg; Jessica L Buicko; Brendan Finnerty; Rasa Zarnegar; Thomas J Fahey; Toni Beninato Journal: Surgery Date: 2019-05-02 Impact factor: 3.982
Authors: Emad Kandil; Barath Krishnan; Salem I Noureldine; Lu Yao; Ralph P Tufano Journal: ORL J Otorhinolaryngol Relat Spec Date: 2013-03-12 Impact factor: 1.538
Authors: Ian Mitchell; Edward H Livingston; Alice Y Chang; Shelby Holt; William H Snyder; Ildiko Lingvay; Fiemu E Nwariaku Journal: Surgery Date: 2007-12 Impact factor: 3.982
Authors: Mohamed Abdelgadir Adam; John Pura; Lin Gu; Michaela A Dinan; Douglas S Tyler; Shelby D Reed; Randall Scheri; Sanziana A Roman; Julie A Sosa Journal: Ann Surg Date: 2014-10 Impact factor: 12.969
Authors: Whitney Sutton; Philip K Crepeau; Joseph K Canner; Shkala Karzai; Dorry L Segev; Aarti Mathur Journal: Am J Surg Date: 2022-02-01 Impact factor: 3.125
Authors: Elisa Pasqual; Julie Ann Sosa; Yingxi Chen; Sara J Schonfeld; Amy Berrington de González; Cari M Kitahara Journal: Thyroid Date: 2022-03-15 Impact factor: 6.506